首页|血清miR-21、IL-6、IL-17联合检测在子宫内膜癌诊断中的意义

血清miR-21、IL-6、IL-17联合检测在子宫内膜癌诊断中的意义

Significance of combined detection of serum miR-21,interleukin-6 and interleukin-17 in the diagnosis of endometrial cancer

扫码查看
目的 探讨微小核糖核酸21(miR-21)、白细胞介素6(IL-6)、白细胞介素17(IL-17)联合检测在子宫内膜癌(EC)诊断中的意义及其机制.方法 回顾性分析连云港市第二人民医院2020年3月至2023年3月诊治的经病理学检查确诊的EC患者(EC组)40例的临床资料,另选取该院同期健康志愿者40例为对照组,采用实时荧光定量聚合酶链反应(qRT-PCR)检测两组血清miR-21水平,采用酶联免疫吸附法(ELISA)检测两组血清IL-6、IL-17水平.结果 EC组患者血清IL-17[(37.22±13.08)ng/L]、IL-6[(12.09±3.99)ng/L]、miR-21[(2.83±0.93)]水平均显著高于对照组[(15.72±8.96)ng/L、(3.93±2.19)ng/L、(1.20±0.39)],差异均有统计学意义(t=8.58、11.34、10.20,均P<0.001).经Pearson相关性分析显示,EC组血清IL-17与IL-6水平呈显著正相关(r=0.97,P<0.001),IL-17水平与miR-21表达量呈显著正相关(r=0.96,P<0.001),IL-16水平与miR-21表达量呈显著正相关(r=0.99,P<0.001).受试者工作特征曲线(ROC曲线)分析显示,IL-17临界值为21.65 ng/L时,诊断EC的敏感度为80.0%,特异度为87.5%,曲线下面积(AUC)为0.894[95%置信区间(95%CI):0.827~0.961,P<0.001];IL-6 临界值为 7.44 ng/L时,诊断 EC 的敏感度为 85.0%,特异度为 92.5%,AUC为0.959(95%CI:0.923~0.995,P<0.001);miR-21 临界值为 1.85时,诊断EC 的敏感度为77.5%,特异度为 92.5%,AUC 为0.947(95%CI:0.905~0.989,P<0.001).结论 该研究证实血清 IL-17、IL-6 和miR-21在一定程度上可以早期预测EC,三者联合检测诊断的价值更高.
Objective To study the significance and mechanism of miR-21,interleukin-6,interleukin-17 in the diagnosis of endometrial cancer.Methods A retrospective analysis was condueted on the clinical data of 40 endometrial cancer patients and 40 healthy volunteers admitted to Lianyungang Second People's Hospital from March 2020 to March 2023.Real time fluorescence quantitative PCR was used to detect serum miR-21 levels and enzyme-linked immunosorbent assay was used to detect serum interleukin-6 and interleukin-17 levels in both groups.Results The serum levels of interleukin-17[(37.22±13.08)ng/L],interleukin-6[(12.09±3.99)ng/L],and miR-21[(2.83±0.93)]in the endometrial cancer group were significantly higher than those in the normal control group[(15.72±8.96)ng/L,(3.93±2.19)ng/L,(1.20±0.39),respectively](t=8.58,11.34,10.20,all P<0.001).Pearson correlation analysis showed that there was a significant positive correlation between serum interleukin-17 and interleukin-6 levels in patients with endometrial cancer(r=0.97,P<0.001),between interleukin-17 level and miR-21 expression in patients with endometrial cancer(r=0.96,P<0.001),and between interleukin-16 level and miR-21 expression in patients with endometrial cancer(r=0.99,P<0.001).Receiver operating characteristic curve analysis showed that when the cut-off value of interleukin-17 was 21.65 ng/L,the sensitivity of the diagnosis of endometrial cancer was 80%,the specificity was 87.5%,and the area under the curve was 0.894[95%confidence interval(CI)=0.827-0.961,P<0.001];when the cut-off value of interleukin-6 was 7.44 ng/L,the diagnostic sensitivity was 85.0%,the specificity was 92.5%,and the area under the curve was 0.959(95%CI=0.923-0.995,P<0.001);when the cut-off value of miR-21 was 1.85,the diagnostic sensitivity was 77.5%,the specificity was 92.5%,and the area under the curve was 0.947(95%CI=0.905-0.989,P<0.001).Conclusion This study confirmed that serum interleukin-17,interleukin-6,and miR-21 could potentially serve as early predictors of endometrial cancer to a certain extent.The combined evaluation of these three parameters may be more valuable for diagnosis.

Endometrial neoplasmsEarly diagnosisSerologic testsRibonucleasesInterleukin-6Interleukin-17Sensitivity and specificity

胡娟、颜圣昊嵩、商安全

展开 >

连云港市第二人民医院检验科,连云港 222006

南京医科大学康达学院检验系,连云港 222006

子宫内膜肿瘤 早期诊断 血清学试验 核糖核酸酶 白细胞介素6 白细胞介素17 敏感性与特异性

江苏省连云港市卫生计生科技计划

202224

2024

中国基层医药
中华医学会,安徽医科大学

中国基层医药

影响因子:1.003
ISSN:1008-6706
年,卷(期):2024.31(5)
  • 4